Recent news on Faslodex

AstraZeneca actions under US review  -  May 3, 2007
Philadelphia Inquirer,...that managers like Zubillaga had been pushing sales representatives to make unfounded and improper pitches for cancer drugs Arimidex and Faslodex.

Wunderman wins AstraZeneca’s Faslodex  -  Apr 20, 2007
DM News,Pharmaceuticals marketer AstraZeneca has tapped Wunderman New York to launch a consumer campaign for Faslodex, a later-stage breast cancer prescription drug

Wunderman Lands Cancer Drug  -  Apr 6, 2007
Adweek,NEW YORK Wunderman here has landed consumer-directed creative duties on AstraZeneca Pharmaceuticals' Faslodex cancer drug after a review, the WPP Group shop

Overall Approximately 3 Million Women in the US Are Living With ...  -  Apr 13, 2007
Genetic Engineering News (press release),In the past decade the regulatory authorities in US have approved five hormone-based therapies (Faslodex, Femara, Aromasin, Nolvadex and Arimidex),

Secret AstraZeneca Audio Tapes: Violation of Corporate Integrity ...  -  Apr 22, 2007
OpEdNews,Proof of this is two audio tracks from the "Arimidex/Faslodex," "Pharmaceutical Sales Specialist Objection Handler for the Tablet PC," which is a CD that

AstraZeneca's sales practices questioned  -  Apr 17, 2007
The News Journal,The letter said AstraZeneca's salesmen were encouraged in a November 2006 meeting to promote the company's Faslodex cancer drug for so-called "off-label"

Cancer patients laud Edwards  -  Mar 28, 2007
Rocky Mountain News,...regimen of medicine: Zometa to rebuild bones; Herceptin, to stop estrogen from feeding cancer cells; and Faslodex, to boost the power of the Herceptin.

Faslodex® Benefits Subset of Women Resistant to Aromatase Inhibitors  -  Feb 1, 2007
Cancer Consultants (press release),Among women with advanced breast cancer that progresses after therapy with an aromatase inhibitor, treatment with the antiestrogen drug Faslodex®

Aromasin® and Faslodex® Similarly Effective and Safe As Second ...  -  Jan 2, 2007
Cancer Consultants (press release),According to results recently presented at the 2006 San Antonio Breast Cancer Symposium (SABCS), Aromasin (exemestane) and Faslodex (fulvestrant)

New Faslodex(TM) (fulvestrant) Data Fill 'treatment Gap' For Women ...  -  Jan 1, 2007
Medical News Today (press release),AstraZeneca has announced the first results from a major clinical trial, EFECT (Evaluation of Faslodex vs Exemestane Clinical Trial), at the annual San

Analysis: Stopping breast-cancer return  -  Dec 19, 2006
Science Daily (press release)...sold as Faslodex, appeared as efficacious as the daily oral aromatase inhibitor exemestane, marketed as Aromasin, in women battling the disease.

Aromasin® and Faslodex® Similarly Effective and Safe in Previously ...  -  Dec 18, 2006
Cancer Consultants (press release),According to results recently presented at the 2006 annual San Antonio Breast Cancer Symposium, Aromasin® (exemestane) and Faslodex® (fulvestrant)

New Faslodex(TM) (Fulvestrant) Data Fill 'Treatment Gap' for Women ...  -  Dec 16, 2006
Nieuwsbank (abonnement),1) The data confirm that FASLODEX(TM) (fulvestrant) - an oestrogen receptor antagonist, and the first of a new type of endocrine therapy - is a valuable

SABCS: Aromasin and Faslodex Found Equivalent in Advanced Breast ...  -  Dec 16, 2006
MedPage Today,Advise patients who ask that this study suggests that Aromasin (exemestane) and Faslodex (fulvestrant) are equivalent when used to treat women with advanced

Analysis: Stopping breast-cancer return  -  Dec 19, 2006
Science Daily (press release)...sold as Faslodex, appeared as efficacious as the daily oral aromatase inhibitor exemestane, marketed as Aromasin, in women battling the disease.

Fulvestrant Equivalent to Exemestane in Second-Line Treatment ...  -  Dec 18, 2006
DG NewsThe study -- Evaluation of Faslodex vs Exemestane Clinical Trial (EFECT) -- represents the first phase 3 clinical trial of this treatment in this patient

Women With Early Breast Cancer are More Likely to Remain Cancer ...  -  Nov 16, 2006
campus med,...'ARIMIDEX', 'CASODEX', 'FASLODEX', 'NOLVADEX', 'ZOLADEX', 'TOMUDEX', and 'IRESSA' are trademarks, the property of the AstraZeneca group of companies.

Celtic Pharma Appoints Two New Senior Executives  -  Nov 21, 2006
PR Newswire (press release),...including Zoladex, Casodex, Arimidex, Tomudex and Faslodex, as well as leading the Phase III program for the novel antipsychotic, Seroquel.



Patients learn to live with advanced breast cancer  Apr 4, 2006
She's currently on Faslodex, which prevents cancer cells from feeding on estrogen in her system. The treatment initially shrank recurring tumors on her scalp. ... - Rochester Democrat and Chronicle

Uncle Sam vets the names of potential drugs  Mar 17, 2006
...drug Glyset. AstraZeneca PLC worked with Mr. Di Domizio to save the name Faslodex for a breast-cancer drug. The company already ... - Pittsburgh Post Gazette

The Thinkers: Celebrity deaths shine light on lung cancer  Mar 26, 2006
At Pitt's labs, she is involved with studies of Faslodex, an anti-estrogen drug, and antibodies to a natural substance called hepatocyte growth factor. ... - Pittsburgh Post Gazette

Female non-smokers suffer disproportionately  Mar 7, 2006
She and Schiller are involved in research looking at whether Faslodex, an anti-estrogen drug used to treat metastatic breast cancers that contain estrogen ... - USA Today

This site is for informational purposes only--it does not offer medical advice or sell health products. If you need assistance, contact your physician or healthcare professional